Patient Facts Study Results Part III: SSDQA Comparison
Created
Loading...
Files
1 Download↓
Last Modified
Findings
Tags
Domain
Publisher
PEDSnet
Abstract
The results of a Patient Facts check using the Multi-Site, Anomaly Detection, Longitudinal parameters. This check investigates longitudinal trends in key domains, with a focus on important study variables like ANC, MCV, & hemoglobin labs and hydroxyurea.
Affiliation(s)
Funder(s)
Provenance
Description
- The anomalous longitudinal trends noted in National, Seattle, and Nationwide’s data in the version of this analysis run against the previous cohort (Part II) still appear here.
- Stanford, new to this version of the cohort, generally trends below the rest of the network for labs at hematology visits. This is consistent with other checks executed from this module.
- Stanford also has poor data availability pre-2015, which is a known issue that is reflected in these results.
- Hydroxyurea (not evaluated in prior executions of this analysis) is poorly populated at Nationwide & Lurie. National has the best population of this drug consistently across the entire time series.
Response to Findings
The issues with Stanford's lab data availability at hematology visits & prescription drug availability at ED visits will need to be further evaluated.
Clinical Subjects Headings
Development Code
Vocabulary
Related Publications
Creative Commons license
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 license.
Cite this Data Quality Result
Wieand, K. (2025, September). Patient Facts Study Results Part III: SSDQA Comparison. [D Q Result]. PEDSpace Knowledge Bank. https://doi.org/10.24373/pdsp-605

